Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mytify
- Development stage
- Unknown
- Lead developer
- Goldline Pharmaceutical
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Mytify is a marketed multivitamin, multimineral, and nutritional supplement developed by Goldline Pharmaceutical. Formulated as tablets, oral drops, and syrups, it is designed to address nutritional deficiencies, support immune function, promote healthy growth and development, and maintain overall health and well-being. The formulation typically contains a comprehensive blend of essential vitamins (such as Vitamin A, Vitamin C, Vitamin D3, and B-complex vitamins), minerals (including Zinc and Selenium), amino acids (such as L-lysine), and in some pediatric formulations, colostrum to support gut health and immune defense.
- Brand names
- MytifyMytify Junior
Beyond the preview
Go deeper on Mytify.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mytify.